TALC INHALATION CARCINOGENICITY ISSUE MAY NEED MORE STUDY
This article was originally published in The Rose Sheet
Executive Summary
TALC INHALATION CARCINOGENICITY ISSUE MAY NEED MORE STUDY, FDA Office of Cosmetics and Colors Acting Director John Bailey, PhD, said at a recent workshop on talc safety cosponsored by FDA and the International Society of Regulatory Toxicology and Pharmacology. "It sounds as if we're leaning in the direction of needing more studies," Bailey said, following a discussion of inhalation data on the ingredient. The workshop was held Jan. 31 and Feb. 1 at the National Institutes of Health campus in Bethesda, MD.